News Detail

Verra Mobility Q2 FY26 turns to net loss of $48.2 million; revenue rises 12% to $263.6 million

PUBT · 13h ago

Listen to the news

Verra Mobility Q2 FY26 turns to net loss of $48.2 million; revenue rises 12% to $263.6 million

Verra Mobility posts Q2 2026 revenue up 12% to USD 263.6 million; net results swing to a USD 48.2 million loss.
Adjusted EBITDA rises to USD 110.7 million from USD 105.3 million; adjusted EBITDA margin falls 3 percentage points to 42%.
Operating cash flow drops to USD 56.4 million from USD 75.1 million; free cash flow slips to USD 32.6 million from USD 40.3 million.
Extended key Commercial Services contracts: seven-year Avis Budget extension, five-year Hertz extension; both on materially less favorable terms with fleet-volume modulation rights.
Revised 2026 outlook: revenue USD 945-965 million, adjusted EBITDA USD 360-370 million, adjusted EPS USD 1.11-1.17, free cash flow USD 105-115 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Verra Mobility Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608051605PR_NEWS_USPR_____LA19509) on August 05, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.